Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01606501 · ClinicalTrials.gov registry record

Outcomes Following Severe Distal Tibia, Ankle and/or Foot Trauma: Comparison of Limb Salvage Versus Transtibial Amputation Protocol

A clinical trial of Severe Distal Tibia Injury and Severe Ankle Injury, sponsored by Major Extremity Trauma Research Consortium.

Completed
Registry status
664
Enrollment target
20
Study locations

NCT01606501 is a study of Severe Distal Tibia Injury and Severe Ankle Injury that has completed, run by Major Extremity Trauma Research Consortium. The registered enrollment target is 664 participants. The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01606501, a study of Severe Distal Tibia Injury and Severe Ankle Injury, has completed, sponsored by Major Extremity Trauma Research Consortium.

COMPLETED
Registry status
664 participants
Enrollment target
20
Study locations

Study Summary

The primary aim this prospective longitudinal observational outcomes study is to compare 18 month functional outcomes and health related quality of life (HRQoL) of patients undergoing salvage versus amputation following severe distal tibia, ankle and/or foot fractures with major soft tissue, bone and/or ankle articular surface loss. Functional outcomes and HRQoL will be measured using well established self reported measures, including the Veterans Rand Health Survey (VR-12) and the Short Musculoskeletal Functional Assessment (SMFA). Hypothesis 1: As a group, salvage patients with severe distal tibia, ankle and/or foot injuries with major soft tissue, bone and/or ankle articular surface loss will have similar functional outcomes and HRQoL had they undergone a transtibial amputation (within 6 weeks of injury). Hypothesis 2: The subgroup of salvage patients who have either (1) a soft tissue injury that requires tissue transfer; (2) articular damage requiring arthrodesis of the ankle joint; or (3) bone loss at the distal tibia or ankle will have better functional outcomes and HRQoL had they undergone a transtibial amputation (within 6 weeks of injury).

Study Locations (20)

Florida

  • University of Miami Ryder Trauma Center - Miami
  • Orlando Regional Medical Center - Orlando
  • Florida Orthopaedic Institute, St. Joseph's Hospital - Tampa
  • Florida Orthopaedic Institute, Tampa General Hospital - Tampa

Indiana

  • Eskenazi Health - Indianapolis
  • OrthoIndy Methodist Hospital - Indianapolis
  • St. Vincent Indianapolis Hospital - Indianapolis

California

  • Navy Medical Center San Diego - San Diego
  • University of California San Francisco Medical Center - San Francisco

Missouri

  • Barnes Jewish Hospital - St Louis
  • St. Louis University Medical Center - St Louis

Alabama

  • University of Alabama at Birmingham - Birmingham

Colorado

  • Denver Health and Hospital Authority - Denver

District of Columbia

  • Walter Reed National Military Medical Center - Washington D.C.

Iowa

  • University of Iowa Medical Center - Iowa City

Trial Details

FieldValue
Enrollment Target 664 participants
Start Date 2012-05
Est. Completion 2019-09-20

What the Registry Record Tells You About NCT01606501

The ClinicalTrials.gov registry entry for NCT01606501 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 664 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Major Extremity Trauma Research Consortium, which has 30 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Severe Distal Tibia Injury appearing as the primary indexed condition, and to 0 interventions.

NCT01606501 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Florida, Indiana, California.

Frequently Asked Questions

What is clinical trial NCT01606501 about?

NCT01606501 is a clinical study titled "Outcomes Following Severe Distal Tibia, Ankle and/or Foot Trauma: Comparison of Limb Salvage Versus Transtibial Amputation Protocol". The primary aim this prospective longitudinal observational outcomes study is to compare 18 month functional outcomes and health related quality of life (HRQoL) of patients undergoing salvage versus amputation following severe distal tibia, ankle and/or foot fractures with major soft tissue, bone an...

What is the current status of trial NCT01606501?

This trial is currently completed. The enrollment target is 664 participants. The study started on 2012-05. Estimated completion is 2019-09-20.

What conditions does trial NCT01606501 study?

This clinical trial studies the following conditions: Severe Distal Tibia Injury, Severe Ankle Injury, Severe Foot Injury, Major Soft Tissue Loss, Major Bone Articular Surface Loss.

Who is sponsoring clinical trial NCT01606501?

This trial is sponsored by Major Extremity Trauma Research Consortium, which has 30 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01606501 being conducted?

This trial has 20 study locations across Alabama, California, Colorado, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.